Centre d'actualités >
Articles spécialisés
-
Dernières nouvelles sur la COVID-19
En apprendre davantage -
Quatre choses que nous savons désormais sur l'amylose AL, une maladie rare
En apprendre davantage
Janssen à la une
Communiqués de presse
Apr 16, 2021
United States
Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia Gravis (gMG) at the 2021 American Academy of Neurology Virtual Meeting
Apr 14, 2021
United States
Johnson & Johnson Statement on CDC Advisory Committee Meeting on Company COVID-19 Vaccine
Apr 06, 2021
United States
New Real-World Observational Analysis of UPTRAVI® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients
Apr 02, 2021
United States
Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents
Tweets
Janssen Global
@JanssenGlobal
-
Attending the @AANMember Virtual Annual Meeting? Listen as Allitia DiBernardo, Head of Global Medical Affairs for N… https://t.co/uRcGFpqrgN
1 hour 53 min ago